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Acetyl-CoA synthase from Clostridium thermoaceticum (ACSCt) is
an a2b2 tetramer containing two novel Ni-X-Fe4S4 active sites (the
A and C clusters) and a standard Fe4S4 cluster (the B cluster). The
acsA and acsB genes encoding the enzyme were cloned into
Escherichia coli strain JM109 and overexpressed at 37oC under
anaerobic conditions with Ni supplementation. The isolated re-
combinant His-tagged protein (AcsAB) exhibited characteristics
essentially indistinguishable from those of ACSCt , from which Ni
had been removed from the A cluster. AcsAB migrated through
nondenaturing electrophoretic gels as a single band and contained
a 1:1 molar ratio of subunits and 1.0–1.6 Niyab and 14–22 Feyab.
AcsAB exhibited 100–250 unitsymg CO oxidation activity but no
COyacetyl–CoA exchange activity. Electronic absorption spectra of
thionin-oxidized and CO-reduced AcsAB were similar to those of
ACSCt, with features typical of redox-active Fe4S4 clusters. Partially
oxidized and CO-reduced AcsAB exhibited EPR signals with g
values and low spin intensities indistinguishable from those of the
Bred state of the B cluster and the Cred1 and Cred2 states of the C
cluster of ACSCt. Upon overnight exposure to NiCl2, the resulting
recombinant enzyme (ACSEc) developed 0.06–0.25 unitsymg ex-
change activity. The highest of these values is typical of fully active
ACSCt. When reduced with CO, ACSEc exhibited an EPR signal
indistinguishable from the NiFeC signal of Ni-replete ACSCt. Vari-
ability of activities and signal intensities were observed among
different preparations. Issues involving the assembly of these
metal centers in E. coli are discussed.
Certain archaea and bacteria grow chemoautotrophically us-ing the WoodyLjungdahl pathway (1). The central enzyme
of this pathway is acetyl-CoA synthase (ACS), also called carbon
monoxide dehydrogenase (CODH). The enzyme from Clostrid-
ium thermoaceticum (ACSCt) catalyzes two reactions, including
the reversible reduction of CO2 to CO, and the synthesis of
acetyl-CoA from CO, CoA, and a methyl group bound to a
corrinoid-iron-sulfur protein (2). This corrinoid protein is meth-
ylated by methyltetrahydrofolate in a reaction catalyzed by a
methyltransferase.
ACSCt is an a2b2 tetramer containing three types of metal-
sulfur clusters called A, B, and C (2, 3). The B and C clusters are
located in the b subunit, whereas the A cluster is located in a.
The B cluster is a standard [Fe4S4]21/11 cluster involved in
electron transfer (4), and it exhibits an EPR signal with gav 5 1.94
when reduced to the Bred state (5). The C cluster is the active site
for CO2yCO redox catalysis (6–9) and likely consists of an Ni
complex weakly coupled through an unidentified bridge to an
Fe4S4 cluster (10, 11). The one- and three-electron reduced Cred1
and Cred2 states exhibit EPR signals with gav 5 1.82 and 1.86,
respectively. The A cluster is the active site for acetyl-CoA
synthesis and is also composed of an Ni center bridged to an
Fe4S4 cluster (12–15). The Ni ion of the A cluster is labile and
can be removed easily by incubating ACSCt in the chelator
1,10-phenanthroline. The Ni ion is readily reinserted by incu-
bating phenanthroline-treated enzyme with NiCl2 (13–15).
When the A cluster is reduced by one electron and bound with
CO, it yields a state (Ared-CO) that exhibits the so-called NiFeC
EPR signal (g 5 2.08, 2.07, 2.03). For unknown reasons, only a
fraction of the A, B, and C clusters are redox and catalytically
active (16). This heterogeneity is reflected in the low spin
intensities of the NiFeC, gav 5 1.94, 1.82, and 1.86 signals (’0.2,
0.6, 0.3, and 0.3 spinsyab, respectively).
In C. thermoaceticum, the enzymes involved in the Woody
Ljungdahl pathway are encoded by the acs genes (17–19). Genes
acsA and acsB encode the b and a subunits of ACSCt, respec-
tively. Genes acsC and acsD encode the corrinoid-iron-sulfur
protein subunits, and acsE encodes methyltransferase. The acs
genes contain promoter-like sequences and translational signals
that are recognized by Escherichia coli. Roberts et al. have cloned
and expressed these genes in E. coli and found that only AcsE was
catalytically active (17, 19). AcsCD was inactive but could be
activated by incubation with cobalamin, iron, and sulfide ions
(20). AcsAB was inactive, but a method of activation has not
been reported. Roberts et al. reported that the recombinant a
and b subunits migrated independently on nondenaturing elec-
trophoretic gels, indicating the absence of the native tetrameric
structure (17). They suggested that AcsAB was inactive because
the bacteria were grown aerobically without metal ion supple-
mentation. Morton et al. (19) later suggested that recombinant
subunits might lack competent NiFeS centers. Genes encoding
ACS homologs in methanogenic archaea have been sequenced,
cloned, andyor overexpressed in E. coli (21–28), but to our
knowledge no active recombinant enzyme from a methanogen
has been reported.
The purple nonsulfur photosynthetic Rhodospirillum rubrum
contains a monomeric carbon monoxide dehydrogenase homol-
ogous to the b subunit of ACSCt (29). CODHRr exclusively
catalyzes the reversible oxidation of CO to CO2 (30) and
contains only the B and C clusters. The cooS gene encoding this
enzyme has been cloned and sequenced (31). Using conjugative
mating followed by homologous recombination, the gene was
introduced into a strain of R. rubrum lacking functional
CODHRr. This elegant method afforded functional enzyme and
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allowed the construction and study of numerous functional
site-directed mutants (32, 33). It has also allowed consideration
of issues involving the assembly of the metal-sulfur clusters.
Roberts and coworkers have identified three genes (cooCTJ),
deletions in which result in Ni-deficient CODHRr (31). This
suggests that CooC, CooT, and CooJ play roles in inserting Ni
into CooS during maturation. CooC possesses a nucleotide-
binding ‘‘P-loop’’ region and is homologous to GTPases required
to insert Ni into urease and NiFe hydrogenases (34–37).
Given the tremendous utility of recombinant metalloenzyme
systems, we wanted to generate active enzyme by overexpressing
cloned acsAB. However, because of the reported inability of E.
coli to serve as a host for this, our strategy was to clone and
manipulate acsA and acsB in E. coli and then introduce them into
a host containing accessory proteins required for ACS metal
cluster assembly. In this paper, we describe the surprising result
that the purified recombinant AcsAB from E. coli is a tetramer
that contains assembled B and C clusters and exhibits CO
oxidation activity levels typical of native ACSCt. Furthermore,
the recombinant protein can be activated by treatment with
NiCl2 to afford COyacetyl-CoA exchange activity and the NiFeC
EPR signal, indicative of assembled A cluster. Thus, the acti-
vated recombinant protein is essentially indistinguishable from
native ACSCt. Implications of these results for probing the
mechanism of cluster assembly and the origin of heterogeneity
are discussed.
Materials and Methods
Materials. Restriction enzymes, T4 DNA ligase, alkaline phos-
phatase, isopropylthio-b-D-galactoside and anti-rabbit IgG (Fc)
AP conjugate were from Promega. Taq polymerase was from
Perkin–Elmer. Ni-nitrilotriacetic acid (Ni-NTA) agarose, E. coli
strain M15(pREP4), QiaPrep spin miniprep kit, QIAquick PCR
purification kit, and vector pQE-60 were purchased from Qia-
gen. This vector was used to install a His-tag at the C terminus
of the a subunit of cloned acsAB. Anti-ACSCt rabbit serum was
prepared by Alpha Diagnostics (San Antonio, TX).
Cloning of acsAB. C. thermoaceticum cells were grown as described
(38) under CO2yH2 in a Coy Laboratory Instruments chamber.
Genomic DNA was isolated using the DNA isolation kit from
Puregene. PCR primers 59-GGCGAGATCTGAATTCATCCT-
CAACCAC-39 and 59-GGCGAGATCTCATAATGGGATC-
CATGGT-39, designed to hybridize to the ends of acsA and acsB,
were synthesized by Genosys (The Woodlands, TX). Genes
acsAB were amplified from genomic DNA using these primers,
a Stratagene Gradient 96 Robocycler, and a PCR optimizer kit
(Invitrogen). The resulting 4.5-kilobase PCR product was puri-
fied with the QIAquick PCR purification kit and digested with
BglII. Vector pQE-60 was digested with BglII and incubated with
alkaline phosphatase to prevent self-ligation. The digested vec-
tor and PCR product were ligated and transformed into
M15(pREP4) competent cells. Plasmid pT316 was isolated from
kanamycin- and ampicillin-resistant colonies.
Double-strand sequencing by the Gene Technologies Labo-
ratory (Department of Biology, Texas A&M University) re-
vealed that pT316 contained acsAB, albeit with three mutations
relative to that reported by Morton et al. (19). One mutation was
silent, one yielded Ser instead of Pro at position 259 in AcsA, and
the third yielded Asp instead of Glu at position 527 of AcsB. A
second cloning (from genomic DNA) and sequencing of the two
affected regions indicated Pro-259 in AcsA and Asp-527 in AcsB.
This suggests that native acsA and acsB encode Pro-259 and
Asp-527, respectively. The QuikChange site-directed mutagen-
esis kit (Stratagene) was subsequently used to change Ser-259 to
Pro-259. The resulting plasmid, pTM02, was subsequently trans-
formed and expressed in E. coli strain JM109 [e14-(McrA-) recA1
endA1 gyrA96 thi-1 hsdR17(rK2 mK1) supE44 relA1 D(lac-proAB)
F9 traD36 proAB lacIqZDM15] (Stratagene).
Expression of AcsAB. E. coli JM109 (pTM02) cells were grown in
25 liters of Begg’s medium (1% tryptoney0.5% yeast extracty
0.4% glucosey100 mM potassium phosphate, pH 6.5y15 mM
sodium formatey1 mM sodium molybdatey1 mM sodium selen-
itey5 mM NiCl2) (39) under stirred (100 rpm) anaerobic (N2)
conditions using a custom-made (Chemglass, Inc.) water-
jacketed all-glass Bioreactor maintained at 37°C with a refrig-
erated recirculator (Polysciences). When the optical density of
cells reached 0.65–0.75 at 600 nm (1-cm path length), isopro-
pylthio-b-D-galactoside and NiCl2 were added to final concen-
trations of 0.1 and 0.5 mM, respectively. Cells were harvested
anaerobically and frozen in liquid N2. The presence of AcsAB,
and thus the expression of acsAB, was indicated by Western
blotting (40).
Purification of AcsAB. Using standard anaerobic methods (38),
70 g of frozen cells, 70 mg of lysozyme, and a trace of DNase were
suspended in 350 ml of buffer A (50 mM NaPi, pH 8.0y0.3 M
NaCly10 mM b-mercaptoethanol). After 1 h, the suspension was
sonicated (Branson Sonifier 450) at room temperature for 5 min
using 1-s pulses (duty cycle constant 60% and output control 7),
and then centrifuged at 23,500 3 g with a GSA rotor (Sorvall)
for 1.5 h. The supernatant was loaded onto an Ni-NTA agarose
column (1.6 3 12 cm) equilibrated in buffer A. The column was
washed with 100 ml of 10 mM imidazole in buffer A and then
eluted with 100 mM imidazole in buffer A. The brown-colored
eluent was diluted 43 with buffer B (50 mM Tris-Cl, pH 8.0y10
mM DTTy2 mM sodium dithionite) and loaded on a DEAE
column (2.6 3 15 cm) equilibrated in buffer B. The column was
washed with 150 ml of 0.2 M NaCl in buffer B followed by 300
ml of a 0.2–0.4 M gradient of NaCl in buffer B. Fractions
exhibiting CO oxidation activity were combined, concentrated,
and frozen in liquid N2.
One batch of AcsAB was isolated as described (38) without the
use of the Ni-NTA agarose column and further purified by
FPLC, as described (41) using a POROS 50D column (PerSep-
tive Biosystems, Framingham, MA), equilibrated in buffer C (50
mM Tris, pH 8.0). After loading, the column was washed with
125 ml of 0.1 M NaCl in buffer C and eluted with 125 ml of a
0.1–0.4 M gradient of NaCl in buffer C.
Characterization and Activation of AcsAB. Sample purity was quan-
tified by scanning Coomassie blue-stained SDSyPAGE gels with
an AlphaImager 2000 (Alpha Innotech, San Leandro, CA)
densitometer. Native gel electrophoresis was performed anaer-
Fig. 1. SDSyPAGE gel (12%) of ACSCt (A) and AcsAB (B).








obically as described (42). CO oxidation and COyacetyl-CoA
exchange activities were performed as described (38, 43). The Ni
and Fe contents of purified AcsAB were determined using
atomic absorption spectrometry (12). EPR spectra of AcsAB
were determined using a Bruker ESP300 spectrometer and an
Oxford Instruments ER910A cryostat. Signals were quantified as
described (44) using a 1.00 mM CuEDTA standard. UV-visible
absorption spectra were determined using a Beckman DU 640B
spectrophotometer. Samples were freed from reductant by pas-
sage through a column of Sephadex G-25 (1 3 17 cm) equili-
brated in buffer D (100 mM Mops, pH 7.5). A sample was
transferred to a quartz cuvette that was subsequently sealed with
a septum and removed from the glove box. Thionin solution was
added until a weak band at 600 nm appeared because of oxidized
thionin, ensuring a fully oxidized sample. Another sample was
reduced by exposure to 1 atm (1 atm 5 101.3 kPa) CO. Protein
concentrations were determined as described (45) using BSA as
a standard. The A cluster of reductant-free AcsAB (’3–8
mgyml21) in buffer D was activated by incubation with 200 mM
(final concentration) NiCl2 overnight under an Ar or CO
atmosphere at room temperature.
Results
Genes acsA and acsB from C. thermoaceticum were cloned and
overexpressed in E. coli. The recombinant protein AcsAB
contained a His-tag, which allowed rapid purification. Samples
were .95% pure according to densitometric analysis of SDSy
PAGE gels. AcsAB consisted of two subunits that migrated, in
SDSyPAGE gels, at the same rates as the a and b subunits of
ACSCt (Fig. 1). Based on relative staining densities, the a and b
recombinant subunits were present in a 1:1 molar ratio. More-
over, AcsAB had the same mobility as ACSCt on a nondenaturing
electrophoresis gel (data not shown). These results suggest that
AcsAB possesses the same a2b2 tetrameric structure as ACSCt.
The three batches of AcsAB whose metal contents were
determined contained an average of 1.3 6 0.3 Niyab and 17 6
4 Feyab (Table 1). To address the possibility that the measured
Ni arose from ions that leached from the Ni-NTA column and
bound onto the His-tag of AcsAB during purification, the Ni
content of the batch purified without this column was also
determined. That sample (75% pure) contained 1.7 Niyab
(assuming no Ni in the contaminating proteins), indicating that
the Ni ions measured in the Ni-NTA purified samples were
associated with AcsAB. A control sample of ACSCt contained
1.8 Niyab and 12 Feyab. ACSCt has been reported to contain
2.0 6 0.2 Niyab (n 5 10) and 12 6 2 Feyab (n 5 11).¶ Thus, our
metal analyses suggest that AcsAB contains a full complement
of FeS clusters, relative to ACSCt (i.e., $12 Feyab) and 1.0–1.6
Niyab.
The electronic absorption spectrum of thionin-oxidized Ac-
sAB (Fig. 2) revealed a broad absorption shoulder in the 400-nm
region, caused by the presence of [Fe4S4]21 clusters. Spectral
intensity at 420 nm declined when the protein was exposed to
CO, reflecting the reduction of these clusters to the 11 core
oxidation state. These spectra were similar to those of ACSCt
(51). The extinction coefficient difference (D«420 5 «420 oxi-
dized 2 «420 reduced) quantified to 14.1 mM21cm21 for AcsAB
compared to 14.7 mM21cm21 for ACSCt (51). These results
suggest that AcsAB and ACSCt contain the same number and
types of FeS clusters.
EPR spectra of three batches of reductant-free partially
oxidized AcsAB consisted of two signals (Fig. 3A), one with gav
5 1.82 (g 5 2.01, 1.80, 1.64) and the other with gav 5 1.94 (g 5
2.04, 1.94, 1.90). At 20 mW and 10 K, the gav 5 1.94 and 1.82
signals showed little evidence of saturation (Fig. 3B). At tem-
peratures higher than ’16 K, the gav 5 1.82 signal relaxation
broadened, whereas the gav 5 1.94 signal did not. Quantification
of the gav 5 1.82 signals yielded an average of 0.28 spinyab. In
¶The range of metal contents, CO oxidation, and COyacetyl-CoA exchange activities given
in the text represent compilations of values reported from our laboratory in refs. 2, 5–7,
10, 12–16, 38, 46–51 (indicated uncertainties represent standard deviations).
Fig. 2. Electronic absorption spectra of AcsAB. Solid line, AcsAB exposed to
1 atm CO. Dotted line, AcsAB oxidized with a slight excess of thionin. The slight
feature in the 600-nm region is attributable to absorption from oxidized
thionin. (Inset) Oxidized minus-reduced difference spectrum.
Table 1. Characteristics of purified AcsAB before and after Ni activation
Batch 1 2 3
Mass of cell paste (g) 70 65 80
Ni content before activation (Niyab) 1.5 1.6 1.0
Fe content before activation (Feyab) 16 22 14
CO oxidation activity beforeyafter activation (unitsymg) 160y140 200(220)y250 100(90)y100
CO exchange activity beforeyafter activation (unitsymg) 0y0.06 0y0.15 0y0.25
NiFeC Signal intensity beforeyafter activation (spinyab) 0y0.15 0y0.38 0y0.15
gav 5 1.94 Signal intensity beforeyafter activation (spinyab) 1.12y0.75 0.95(0.55)y0.93 0.83(0.66)y0.82
gav 5 1.82 Signal intensity before activation (spinyab) 0.29 0.31 0.25
gav 5 1.86 Signal intensity beforeyafter activation (spinyab) 0.21y0.24 0.13y0.18 0.08y0.09
Batch 1 was activated with Ni under 1 atm Ar, while batches 2 and 3 were activated under 1 atm CO. Values in parentheses for batches 2 and 3 are from samples
incubated overnight in the absence of reductants and under 1 atm Ar.
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the same redox state, ACSCt exhibits two signals, a gav 5 1.94
signal arising from Bred and a gav 5 1.82 signal from Cred1.
Because the signals in AcsAB have indistinguishable g values and
saturationyrelaxation properties as those in ACSCt, we conclude
that they arise from clusters with the same structures as the B and
C clusters of ACSCt and refer to them by the same names.
Moreover, the average quantified spin intensity of the Cred1 state
of the C cluster in AcsAB (Table 1) is similar to that observed
in ACSCt, indicating a similar proportion of functional C clusters
in ACSCt and AcsAB.
In batches 1 and 2, CO-reduced AcsAB exhibited two EPR
signals, one with gav 5 1.94 and the other with gav 5 1.86 (g 5
1.97, 1.87, 1.75) (Fig. 4A and B). Essentially indistinguishable
signals are observed in spectra of CO-reduced ACSCt. These
signals in ACSCt arise from Bred and Cred2, and we conclude that
the corresponding signals in AcsAB arise from analogous states.
The Bred and Cred2 signals of batch 3 differ slightly from those of
batches 1 and 2 (Fig. 4 C and D). The reason for this is unknown,
but the differences probably reflect minor perturbations in
protein or cluster structure. The gav 5 1.86 and gav 5 1.94 signals
from the three batches quantified to an average of 0.14 spinyab
and 0.97 spinyab, respectively (Table 1). The gav 5 1.94 signal is
’30% more intense than in ACSCt, possibly suggesting a shift in
spin state from S 5 3y2 to S 5 1y2 for the Bred state in AcsAB.
The intensity of the Cred2 signal from AcsAB is about half of that
reported for ACSCt (in ACSCt, both gav 5 1.82 and 1.86 signals
typically quantify to ’0.3 spinyab). We may have underesti-
mated the gav 5 1.86 signal intensity in these spectra, as the
dominating gav 5 1.94 signal is superimposed. Alternatively, the
redox potential for the CintyCred2 couple may be slightly more
negative in AcsAB than in ACSCt, resulting in a greater pro-
portion of C clusters in the EPR-silent Cint state in AcsAB (52).
In any event, the presence of the gav 5 1.86 signal provides
conclusive evidence that the C cluster is present in AcsAB and
has the same basic structure and properties as that in ACSCt.
CO-reduced AcsAB did not exhibit the characteristic NiFeC
EPR signal of CO-reduced ACSCt. To address the possibility that
AcsAB contained a partially assembled A cluster (an assembled
Fe4S4 cluster without Ni), the protein was incubated overnight in
NiCl2. Ni-treated AcsAB, to be called ACSEc, exhibited an EPR
signal (Fig. 5B) with g values, saturationyrelaxation properties,
and spin intensities (Table 1) indistinguishable from the NiFeC
signal of ACSCt. Thus, we conclude that ACSEc contains an A
cluster with redox and spectroscopic properties similar to that in
ACSCt.
Purified ACSEc (which exhibited the NiFeC signal when
reduced with CO) was loaded on the Ni-NTA agarose column,
eluted with 100 mM imidazole, and then subjected to Sephadex
G-25 chromatography to remove excess imidazole and Ni. The
resulting material did not exhibit the NiFeC signal, suggesting
that the Ni-NTA purification step can strip Ni from activated A
cluster.
The catalytic properties of ACSEc and AcsAB were examined.
The three batches of AcsAB and ACSEc exhibited 100 to 250
unitsymg of CO oxidation activity (Table 1). The activity of
batch 2 is within the range of values observed in our laboratory
for fully active ACSCt (280 6 70 unitsymg; n 5 44)¶. The higher
activity of batch 2 AcsAB and ACSEc is also consistent with the
more intense C cluster signals observed for this batch. Enzyme
allowed to incubate overnight in the absence of any reducing
agents resulted in a lower intensity of the Bred signal and CO
oxidation activity, suggesting that AcsAB may not be quite as
Fig. 3. 10 K X-band EPR spectra of AcsAB (batch 2, 6.8 mgyml). (A) Partially
oxidized with thionin, 0.05 mW microwave power; (B) same as A, but at 20 mW
microwave power. Other spectrometer conditions: microwave frequency, 9.42
GHz; modulation frequency, 100 kHz; modulation amplitude, 11.8 G; sweep
time, 164 s; time constant, 328 s.
Fig. 4. 10 K X-band EPR spectra of AcsAB. (A) CO-reduced (batch 2, 6.8
mgyml), 0.05 mW microwave power; (B) Same as A, except 20 mW microwave
power; (C) CO-reduced (batch 3, 4.6 mgyml), 0.05 mW microwave power;
(D) same as C, except 20 mW microwave power. Other conditions were as in
Fig. 3.








stable as ACSCt. None of the AcsAB batches exhibited COy
acetyl-CoA exchange activity, whereas all Ni-treated ACSEc
samples did (Table 1). The activities of batches 2 and 3 were
within the range observed for fully functional ACSCt (0.17 6 0.10
unitsymg; n 5 39). This result demonstrates that ACSEc can
contain fully assembled and functional A cluster.
Discussion
Our results demonstrate that the acsAB genes from C. ther-
moaceticum can be cloned and heterologously expressed in E.
coli to yield a recombinant protein able to catalyze the oxidation
of CO. AcsAB has an a2b2 tetrameric quaternary structure, fully
assembled B and C clusters, and at least the Fe4S4 component of
the A cluster. Because the purification method used seems able
to remove the labile Ni from the A cluster, it is unclear whether
AcsAB in E. coli has a fully assembled A cluster. In any event,
an Ni ion can be inserted in vitro, affording a fully functional A
cluster and enzyme capable of catalyzing COyacetyl-CoA ex-
change. The measured redox and spectroscopic properties of
these clusters are nearly indistinguishable from those of native
ACSCt. In brief, our results indicate that Ni-treated recombinant
enzyme (ACSEc) is essentially equivalent to native ACSCt, ex-
hibiting both catalytic activities and the full complement of metal
clusters that define this enzyme.
These results and conclusion contrast sharply with those of
Roberts et al., who reported that expression of acsAB in E. coli
afforded nonfunctional a and b subunits that migrated inde-
pendently (17). We obtain functional recombinant enzyme, but
of lesser yields, regardless of the strain of E. coli used, the growth
conditions (anaerobic or bubbled with air,i 15–45°C), or the
presence of supplemented Ni in the media. Furthermore, re-
combinant protein seems relatively stable in its tetrameric form.
The results of this study provide a convenient means for
biosynthesizing site-directed mutants of this enzyme. These
mutants could be used to identify ligands to the metal centers as
well as reveal their role in establishing the catalytic, redox,
andyor spectroscopic properties that distinguish these centers.
This achievement also provides a means to study metal cluster
assembly.
Proteins containing novel metal centers, such as urease,
NiFe-hydrogenase, and nitrogenase, have been shown to require
specific accessory proteins for assembly and insertion of their
metal centers (53–58). The previous report of nonfunctional
ACS (17) suggested that such proteins were required for the
biosynthesis of this metalloenzyme but were absent in E. coli.
This was easily rationalized, as E. coli does not naturally contain
ACS, and the metal centers in this enzyme appear to be unique
in biology. Therefore, our success was surprising, as it suggests
that E. coli contains accessory proteins that assemble and insert
the B and C clusters into recombinant AcsAB, as well as the FeS
component of the A cluster. The B cluster and the Fe4S4
components of the C and A clusters may have been assembled
and inserted using IscS and IscU, enzymes in E. coli that catalyze
the formation of FeS clusters (59).
It is intriguing to consider how Ni was inserted into the C
cluster in vivo. A series of gene clusters in E. coli is responsible
for assembling the active sites of the organism’s three NiFe
hydrogenases, including hya, hyb, hyc, and hyp (55, 56, 60–63).
When hypB is deleted, all three hydrogenases lack Ni in their
active sites, suggesting that HypB participates in inserting Ni
into these sites (36, 37). HypB is a homolog of CooC, a protein
involved in inserting Ni into the C cluster of CODHRr (31). We
conjecture that in E. coli, HypB served as a surrogate of CooC
to insert Ni into AcsAB, thereby forming the C cluster. Given
that our batches of AcsAB had somewhat variable CO oxida-
tion activity and C cluster EPR signal intensities, this surrogate
may not be as effective as CooC in assembling the C cluster.
Whether Ni was inserted into the labile Ni site of the A cluster
by accessory proteins in E. coli remains unknown. E. coli may
lack an accessory protein capable of serving as a surrogate for
the unidentified accessory protein in C. thermoaceticum that is
used to insert Ni during A cluster assembly. Alternatively, the Ni
in an assembled A cluster may have been lost during purification.
Fortunately, Ni could be inserted into this site simply by incu-
bating the enzyme overnight in NiCl2.
Finally, these results impact our understanding of the redox
and spin-state heterogeneity that plagues this enzyme. The
evidence for heterogeneity is extensive (5, 10, 13–16, 46, 50)
and will only be summarized here. Approximately 40% of A
clusters contain labile Ni ions, function catalytically, and can
be reduced to the Ared-CO state (exhibiting the NiFeC signal).
The remaining 60% contain nonlabile Ni ions, are nonfunc-
tional, and cannot be reduced. This situation is ref lected in the
low spin intensity of the NiFeC signal. The C cluster is also
heterogeneous. Approximately 40% of C clusters in the Cox
state can be reduced by one, two, and three electrons, forming
Cred1, Cint, and Cred2, respectively. The remaining 60% can be
reduced by one electron to the CS53/2 state. Again, the low spin
intensities of the gav 5 1.82 and 1.86 signals ref lect this
situation. The B cluster appears to exhibit only spin-state
heterogeneity, with about 60% of Bred having an S 5 1⁄2 ground
state (affording the gav 5 1.94 signal) and the remainder having
S 5 3y2 (affording EPR features between g 5 4–6). Obvious
reasons for this heterogeneity, including errors in determining
protein, metal, or spin concentrations or damage incurred
during purification, have been considered and discounted (38).
Fraser and Lindahl recently suggested that heterogeneity
might arise from events occurring during the growth of C.
thermoaceticum (16). However, the results presented here
indicate that the same type of heterogeneity present in ACSCt
plagues recombinant AcsAB (and ACSEc). Thus, it would seem
that the factors causing heterogeneity are independent of the
iBecause E. coli rapidly consumes O2 during growth, we are uncertain as to the aerobicity
of cultures grown while bubbled with air. The fact that functional recombinant enzyme
can be biosynthesized under these conditions merely implies that strict anaerobic condi-
tions are not required.
Fig. 5. 130 K X-band EPR spectra of CO-reduced ACSEc (batch 2, 5.7 mgyml).
(A) before addition of NiCl2 and (B) after addition of NiCl2. Other spectrometer
conditions were as in Fig. 3 except that microwave power was 80 mW.
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host organism and of the accessory proteins used to assemble
the clusters and are intrinsic to the enzyme. Such intrinsic
heterogeneity could arise if the two ab dimers of the a2b2
tetramer were symmetry-inequivalent.
With active recombinant ACS from C. thermoaceticum now
available, we plan to prepare site-directed mutants to help
elucidate details of the catalytic mechanism of this enzyme and
the roles of its metal clusters. We also plan to probe the
mechanism of cluster assembly and uncover the origin of the
heterogeneity.
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